Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

NCT06295562 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea of Adult

Interventions

DRUG: Atomoxetine 80mg combined with oxybutynin 5mg
DRUG: Venlafaxine 37.5mg
DRUG: oxybutynin 5mg combined with trazodone 100mg
DRUG: Placebo

Sponsor

China Medical University Hospital